Intuitive Surgical (NASDAQ:ISRG) Price Target Raised to $687.00

Intuitive Surgical (NASDAQ:ISRG) had its target price upped by Wells Fargo & Company from $630.00 to $687.00 in a research report released on Friday,Benzinga reports. Wells Fargo & Company currently has an overweight rating on the medical equipment provider’s stock.

Several other research firms also recently weighed in on ISRG. Raymond James raised their price target on Intuitive Surgical from $500.00 to $540.00 and gave the stock an “outperform” rating in a research report on Monday, October 14th. Truist Financial lifted their price objective on Intuitive Surgical from $570.00 to $640.00 and gave the company a “buy” rating in a research report on Wednesday, December 18th. Robert W. Baird lifted their price objective on Intuitive Surgical from $503.00 to $565.00 and gave the company an “outperform” rating in a research report on Thursday, October 17th. Oppenheimer reaffirmed a “market perform” rating on shares of Intuitive Surgical in a research report on Friday, October 18th. Finally, Leerink Partners lifted their price objective on Intuitive Surgical from $489.00 to $502.00 in a research report on Thursday, October 17th. One investment analyst has rated the stock with a sell rating, three have given a hold rating and fifteen have given a buy rating to the company’s stock. According to data from MarketBeat, Intuitive Surgical presently has a consensus rating of “Moderate Buy” and an average price target of $583.83.

Intuitive Surgical Price Performance

NASDAQ ISRG opened at $584.05 on Friday. Intuitive Surgical has a 1-year low of $364.17 and a 1-year high of $616.00. The company has a market capitalization of $208.03 billion, a P/E ratio of 93.90, a PEG ratio of 5.19 and a beta of 1.39. The business has a 50 day moving average price of $547.16 and a 200 day moving average price of $504.78.

Insider Activity

In other news, CFO Jamie Samath sold 108 shares of the business’s stock in a transaction that occurred on Tuesday, November 26th. The stock was sold at an average price of $542.06, for a total transaction of $58,542.48. Following the completion of the transaction, the chief financial officer now directly owns 8,757 shares in the company, valued at approximately $4,746,819.42. The trade was a 1.22 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, EVP Robert Desantis sold 188 shares of the business’s stock in a transaction that occurred on Tuesday, October 29th. The stock was sold at an average price of $506.52, for a total value of $95,225.76. Following the transaction, the executive vice president now owns 5,506 shares of the company’s stock, valued at approximately $2,788,899.12. This represents a 3.30 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 42,453 shares of company stock valued at $22,059,506. 0.90% of the stock is currently owned by insiders.

Hedge Funds Weigh In On Intuitive Surgical

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the company. State Street Corp boosted its stake in Intuitive Surgical by 1.4% during the 3rd quarter. State Street Corp now owns 15,050,121 shares of the medical equipment provider’s stock valued at $7,393,673,000 after purchasing an additional 210,363 shares in the last quarter. FMR LLC boosted its stake in Intuitive Surgical by 8.3% during the 3rd quarter. FMR LLC now owns 10,971,085 shares of the medical equipment provider’s stock valued at $5,389,765,000 after purchasing an additional 838,793 shares in the last quarter. Geode Capital Management LLC boosted its stake in Intuitive Surgical by 1.9% during the 3rd quarter. Geode Capital Management LLC now owns 7,512,925 shares of the medical equipment provider’s stock valued at $3,677,194,000 after purchasing an additional 143,440 shares in the last quarter. Fisher Asset Management LLC boosted its stake in shares of Intuitive Surgical by 1.8% during the 3rd quarter. Fisher Asset Management LLC now owns 4,782,381 shares of the medical equipment provider’s stock worth $2,349,441,000 after acquiring an additional 86,208 shares in the last quarter. Finally, Baillie Gifford & Co. boosted its stake in shares of Intuitive Surgical by 0.6% during the 3rd quarter. Baillie Gifford & Co. now owns 3,848,547 shares of the medical equipment provider’s stock worth $1,890,676,000 after acquiring an additional 24,183 shares in the last quarter. 83.64% of the stock is owned by institutional investors.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.